Providing gastrointestinal nurse education during the pandemic

2021 ◽  
Vol 30 (19) ◽  
pp. 1146-1148
Author(s):  
Jennifer Burch
Keyword(s):  
Inflammatory Bowel Disease ◽  
British Journal ◽  
Bowel Disease ◽  
Nurse Education ◽  
North West ◽  
Inflammatory Bowel

Jennifer Burch, Head of Gastrointestinal Nurse Education, St Mark's Hospital, London North West University Healthcare NHS Trust ( [email protected] ), was runner-up in the Gastrointestinal/Inflammatory Bowel Disease Nurse of the Year category of the British Journal of Nursing Awards 2021

scholarly journals Challenges in screening for latent tuberculosis in inflammatory bowel disease prior to biologic treatment: a UK cohort study

2018 ◽  
Vol 9 (3) ◽  
pp. 234-240 ◽  
Author(s):  
Aye Aye Thi ◽  
Aula Abbara ◽  
Sonia Bouri ◽  
Simon M Collin ◽  
Paul Wolfson ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Latent Tuberculosis ◽  
Immunosuppressive Drugs ◽  
Retrospective Case ◽  
Biologic Treatment ◽  
North West ◽  
Ltbi Screening ◽  
Interferon Gamma Release Assays ◽  
Inflammatory Bowel

ObjectiveThe aim of this study was to determine the occurrence of latent tuberculosis infections (LTBI) and active TB in a cohort of patients with inflammatory bowel disease (IBD) treated with biologics. We also examined the effects of immunosuppressive drugs on indeterminate interferon-gamma release assays (IGRA) in LTBI screening.DesignRetrospective study of patients treated with biologics between March 2007 and November 2015.SettingSt Mark’s Hospital, North West London, UK.Patients732 patients with IBD who were screened for LTBI using either tuberculin skin test or IGRA before starting a biologic treatment.MethodsRetrospective case note review of all patients with IBD who were screened for LTBI prior to initiating biologics. Patients who developed active TB were identified from the London TB register.ResultsOf 732 patients with IBD, 31 (4.2%) were diagnosed with and treated for LTBI with no significant side effects. Six of 596 patients (1.0%) who received biologic treatment developed active TB. There was a higher proportion of indeterminate IGRA in the immunosuppressive medication group compared with the non-immunosuppressive group (33% (59/181) compared with 9% (6/66), p<0.001). The combination of steroids and thiopurines had the highest proportion of indeterminate IGRA (64%, 16/25). High and low doses of steroids were equally likely to result in an indeterminate IGRA result (67% (8/12) and 57% (4/7), respectively).ConclusionsThis study highlights the challenges of LTBI screening prior to commencing biologic therapy and demonstrates the risk of TB in patients who have been screened and who are receiving prolonged and continuing doses of antitumour necrosis factor.

scholarly journals Incidence of inflammatory bowel disease in north west Greece: rarity of Crohn's disease in an area where ulcerative colitis is common.

Gut ◽  
1994 ◽  
Vol 35 (3) ◽  
pp. 369-372 ◽  
Author(s):  
E V Tsianos ◽  
C N Masalas ◽  
M Merkouropoulos ◽  
G N Dalekos ◽  
R F Logan
Keyword(s):  
Ulcerative Colitis ◽  
Inflammatory Bowel Disease ◽  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Bowel Disease ◽  
North West ◽  
Inflammatory Bowel

scholarly journals Geographic Distribution, Phenotype and Epidemiological Tendency in Inflammatory Bowel Disease Patients in Romania

Medicina ◽  
2019 ◽  
Vol 55 (10) ◽  
pp. 704
Author(s):  
Adrian Goldiș ◽  
Raluca Lupușoru ◽  
Liana Gheorghe ◽  
Cristian Gheorghe ◽  
Anca Trifan ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Smoking Status ◽  
Age Distribution ◽  
Final Analysis ◽  
Male Population ◽  
North West ◽  
North East ◽  
Inflammatory Bowel

Background and objective: The incidence of inflammatory bowel disease (IBD) over the past years in Romania has been on the rise, but epidemiologic data are lacking. The aim of this study was to define the characteristics of IBD, the trends and phenotype among IBD patients in Romania. Material and methods: We conducted a prospective study over a period of 12 years, from 2006 to 2017. All patients diagnosed with IBD on clinical, radiological, endoscopic and histological features were included. We divided the country into eight regions: west (W), north-east (NE), north-west (NW), south-east (SE), south-west (SW), south (S), central (C) and Bucharest-Ilfov (B), and data were analyzed accordingly. Results: A total of 2724 patients were included in this database, but only 2248 were included in the final analysis, with all data available. Of the 2248 patients, 935 were Crohn’s disease (CD), 1263 were ulcerative colitis (UC) and 50 were IBD-undetermined. In UC phenotypes we observed more frequent left-sided colitis (50.5%, p < 0.0001), and in CD phenotype we observed more frequent colonic and ileo-colonic localization (37.8% and 37.6%, p < 0.0001). The region with the most IBD cases was NE (25.1%) and with the least IBD cases was SW (4.9%). UC was found more frequently in NE (32%), while CD was found more frequently in Bucharest (28.6%). Conclusions: In Romania, ulcerative colitis is more frequent than CD. UC is predominant in the northern part of Romania, while CD has become predominant in the southern part of the country. IBD occurs more in the male population, and in urban and industrialized areas. There are differences between the regions in Romania regarding IBD phenotypes, gender distributions, age distribution, treatment, smoking status and complications.

Helping patients live well with a stoma for inflammatory bowel disease: directions for future research

2019 ◽  
Vol 28 (22) ◽  
pp. S7-S9
Author(s):  
Lesley Dibley ◽  
Jennie Burch
Keyword(s):  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Nurse Education ◽  
Future Research ◽  
Nursing Research ◽  
Inflammatory Bowel ◽  
Research And Education

Lesley Dibley, Reader in Nursing Research and Education, University of Greenwich ( [email protected] ), and Jennie Burch, Head of Gastrointestinal Nurse Education, St Mark's Hospital, outline the need to assess patients' emotional as well as physical needs before stoma surgery for IBD

Differences in Inflammatory Bowel Disease Phenotype between South Asians and Northern Europeans Living in North West London, UK

2011 ◽  
Vol 106 (7) ◽  
pp. 1281-1289 ◽  
Author(s):  
David G Walker ◽  
Horace R T Williams ◽  
Stephen P Kane ◽  
Joel E Mawdsley ◽  
Jayantha Arnold ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
South Asians ◽  
Disease Phenotype ◽  
North West ◽  
Inflammatory Bowel

scholarly journals P741 Incidence and clinical phenotype of inflammatory bowel disease in the north–west of Spain (Vigo) between 1991 and 2011

2020 ◽  
Vol 14 (Supplement_1) ◽  
pp. S593-S593
Author(s):  
M L De Castro Parga ◽  
V De Castro Luisa Hernández ◽  
J R Pineda ◽  
J Martinez Cadilla ◽  
M Figueira ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Clinical Phenotype ◽  
Descriptive Study ◽  
Epidemiological Studies ◽  
North West ◽  
Western Countries ◽  
The North ◽  
Inflammatory Bowel

Abstract Background The incidence of inflammatory bowel disease (IBD) seems to have stabilised in the last two decades in some western countries. Our aim was to analyse changes in the epidemiology of IBD between 1991 and 2011 in the area of Vigo (north–west of Spain). Methods Retrospective and descriptive study of two inception cohorts of IBD patients aged 15 years or more, that were enrolled in the area of Vigo in two European epidemiological studies: EC-IBD performed from 1991 to 1993 and EpiCom performed in 2010 and 2011. The population of Vigo at those moments was of 408.387 and 493.516 inhabitants, respectively. Results In 1991–1993, 102 new IBD cases were diagnosed: 65 ulcerative colitis (UC), 35 Crohn’s disease (CD) and 1 IBD unclassified (IBDU) that showed an incidence of 12.5 cases/100 000 inhabitants per year (8/100 000 inhabitants/year for UC, 4.3/100 000 inhabitants/year for CD and 0.1/100 000 inhabitants/year in IBDU). Regarding 2010–2011, there were 192 cases: 88 UC, 83 CD, 21 IBDU, which an incidence of 19.5 cases/100 000 inhabitants per year (8.9/100 000 inhabitants/year for UC, 8.4/100 000 inhabitants/ year for CD and 2/100 000 inhabitants/year for IBDU) (Figure 1). IBD patients in the second cohort were older: 43.5 (16.4) and 35.8 (16.2) years (p = 0.0005) than the first ones, and IBD diseases also differed in both cohorts (p = 0.001) with more CD (p = 0.03) and IBDU (p = 0.013) in 2010–2011. In 2010–2011 cohort UC patients were older: 39.2 (15.1) vs. 46.1 (16.4) years (p = 0.008) with no differences in gender or phenotype. CD patients were older as well: 29.1 (15.7) vs. 40.4 (15.8) year (p = 0.001), with more patients over their 40s (p = 0.005), and an increase in ileal vs. colonic location (53% vs. 20%, p = 0.006) (Table 1). Conclusion Between 1991 and 2011, an increase in the incidence of IBD in Vigo was demonstrated, mainly in CD and IBDU. The age at IBD diagnosis increased significatively, both in UC and CD.

Sign in / Sign up

Export Citation Format

Share Document